Miltenyi Biotec-tested panel 34 (MBTP 34)
This application protocol describes the characterization of CAR T cell persistence and differentiation using flow cytometry. For this, CAR T cells were spiked into whole blood. The data was analyzed using the automated data acquisition and analysis tool Express Mode “CAR_T_Cell_Persistence_h_01”.
|Specificity||Clone||Purpose||Fluorochrome||Detection filter (nm) (laser)|
|7-AAD Staining Solution||-||Viability||-||655–730 (blue)|
|CD3||REA613||T cells||FITC||525/50 (blue)|
|CD4||REA623||T helper cells||VioGreen™||525/50 (violet)|
|CD8||REA734||Cytotoxic T cells||APC-Vio® 770||750 LP (red)|
|CD45RO||REA611||T cell differentiation||APC||655-730 (red)|
|CD62L||145/15||T cell differentiation||PE-Vio 770||750 LP (blue)|
|CD45RA||REA562||T cell differentiation||VioBlue®||450/50 (violet)|
|Biotin||REA746||CAR T cells||PE||585/40 (blue)|
|CD19 CAR Detection Reagent||-||CAR T cells||-||-|
Unless otherwise specifically indicated, Miltenyi Biotec products and services are for research use only and not for therapeutic or diagnostic use.
If not otherwise specified, all marks displayed on the Miltenyi Biotec Internet site and documents are subject to the trademark rights of Miltenyi Biotec, including each of Miltenyi Biotec's primary brands, its model name plates, and its corporate logos and emblems.
For copyright note and a complete list of trademarks visit www.miltenyibiotec.com/legalnotes.
Seems like you are coming from USA!
Do you want to visit our website in your country?